// App-Quantinova.ai

3579 : APOBEC3 activity sensitizes cells to ATR-Chk1 pathway inhibition

Researchers

Presenter

  • Konstantin Budagyan

Principal Investigators

  • Matthew D. Weitzman

  • Abby M. Green

Medical Centers

  • Childrens Hospital of Philadelphia, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ataxia telangiectasia

  • Solid malignancies

Biomarkers

  • Annexin V

Drug/Treatment

  • Doxycycline

  • VE822

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved